查找临床试验
已按「法布雷病」检索，对应国际通用词 Fabry disease
共找到 39 项正在招募的试验
数据更新于 00:19，每 5 分钟自动同步A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
United States、Austria、France、Norway、Spain 等 6 国
年龄 2 Years – 17 Years
Chiesi Farmaceutici S.p.A.
Taiwan Associated Genetic and Nongenetic Small Vessel Disease
Taiwan
年龄 18 Years – 不限
National Taiwan University Hospital
Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI
Canada
年龄 18 Years – 不限
University Health Network, Toronto
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
United States、Argentina、South Korea
年龄 18 Years – 不限
GC Biopharma Corp
A Study of Agalsidase Alfa Enyzme Replacement Therapy in Chinese Children and Adults With Fabry Disease
China
年龄 7 Years – 不限
Takeda
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
United States、Slovenia、United Kingdom
年龄 18 Years – 不限
Chiesi Farmaceutici S.p.A.
Canadian Fabry Disease Initiative (CFDI) National Registry
Canada
年龄 5 Years – 85 Years
Canadian Fabry Research Consortium
Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease
China
年龄 7 Years – 不限
The Children's Hospital of Zhejiang University School of Medicine
Cardiovascular Multimodality Imaging Study
United States
年龄 18 Years – 不限
Montefiore Medical Center
Evaluation of the Safety, Tolerability and Efficacy of a Gene Therapy Drug for the Treatment of Pediatric Fabry Disease
China
年龄 7 Years – 18 Years
Children's Hospital of Fudan University
A Global Prospective Observational Study of Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
United States
年龄 不限 – 不限
Amicus Therapeutics
Maternal and Postnatal Outcomes Study (MOS): A Global Observational Registry Assessing the Safety of Elfabrio® in Women With Fabry Disease and Their Infants During Pregnancy and Breastfeeding
United States、Germany、Italy、Spain、United Kingdom
年龄 不限 – 不限
Chiesi Farmaceutici S.p.A.